Skip to main content
Clinical Trials/NCT02500056
NCT02500056CompletedNot Applicable

Single-centre Single-blinded Randomised Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty

Tartu University Hospital0 sites143 target enrollmentStarted: January 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
143
Primary Endpoint
Chronic Pain

Study Overview

Brief Summary

The aim of the present study is to determine whether usage of mesh with larger pores, compared with mesh with smaller pores, would result in decreased rate of chronic pain after open inguinal hernia repair.

Detailed Description

The aim of the present study is to determine whether usage of mesh with larger pores, compared with mesh with smaller pores, would result in decreased rate of chronic pain after open inguinal hernia repair. The patients are randomized into two study gropus receiving mesh with different pore size. Clinical follow-up examination will be performed 1 week, 1 month, 6 months and 3 years after the operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age ≥18 years
  • unilateral primary reducible inguinal hernia
  • elective operation
  • consent to participate in the study.

Exclusion Criteria

  • age <18 years
  • irreducible
  • strangulated
  • recurrent hernia
  • inability to understand the questionnaire
  • unwillingness to participate in the study

Outcomes

Primary Outcomes

Chronic Pain

Time Frame: 6-month follow-up

On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise

Secondary Outcomes

  • Chronic Pain(3-year follow-up)
  • Foreign Body Feeling(6-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ceith Nikkolo

Dr.

Tartu University Hospital

Similar Trials